NRXS vs SRPT · rev $3.6M vs rev $1.13B
Neuraxis, Inc. (NRXS) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
NRXS currently screens at market cap $83.1M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the NRXS and SRPT stock pages for the full models.
Not investment advice.